Canada Post labour disruption: Committed to your health, our team works with various carriers to ensure prompt delivery.

Specialist Advice — 7 minutes

Prenatal and preimplantation diagnosis

Raymond Lepage, PhD, Doctor in Biochemistry
Raymond Lepage, PhD, Doctor in Biochemistry
Science popularizer

A prenatal diagnosis (PND) identifies fetal abnormalities or genetic diseases during pregnancy. In the context of a disease already identified in your family, before doing this test, we need to identify whether you have the mutation or, in the case of a recessive transmission disease, whether this mutation is present in both parents. Depending on the disease, even if the mutation is known, the PND can determine whether or not the fetus is affected, but it is not possible to predict the severity of the symptoms.

You can choose one of two procedures for a prenatal diagnosis:

Chorionic villus sampling (placenta biopsy)

  • Done using the DNA extracted from this sample.
  • Undertaken between the 10th and 12th week of pregnancy.
  • An associated risk of fetal loss (miscarriage) of about 1% (1 in 100).
  • An approximately 2% risk of the sample being contaminated with cells of maternal origin. In such cases, the test would not be reliable and an amniocentesis would be required to establish a diagnosis.
  • The accuracy of this prenatal test is assessed at 98%.
  • Results are available 2-3 weeks after the procedure.

Amniocentesis

  • Consists of an amniotic fluid sample.
  • Done using the DNA extracted from this sample.
  • Usually undertaken after the 15th week of pregnancy.
  • An associated risk of fetal loss (miscarriage) between 0.25% (1 in 400) and 0.5% (1 in 200).
  • The accuracy of the test is 99.8%.
  • Results are available 2-3 weeks after the procedure.

As for the Preimplantation Diagnosis (PID), it can detect the presence of potential genetic or chromosomal abnormalities in embryos conceived after in vitro fertilization. In this case, a genetic test is done on a few cells taken from each embryo. Embryos carrying the mutation can therefore be excluded and only unaffected embryos are implanted in the uterus.

The disadvantages of the PID include the associated costs, the ovarian stimulation process, in vitro fertilization, the possibility that few (or no) embryos will be available for transfer and the implantation rate of approximately 30-35%.

We provide services that can help your doctor make a better-informed decision for your medication and dosage.

Take an appointment online or contact Biron Groupe Santé customer service at 1 833 590 -2714.

Raymond Lepage, PhD, Doctor in Biochemistry
Raymond Lepage, PhD, Doctor in Biochemistry
Science popularizer
For about 50 years, Raymond Lepage worked as a clinical biochemist in charge of public and private laboratories. An associate clinical professor at the Faculty of Medicine of the Université de Montréal and an associate professor at the Université de Sherbrooke, he has also been a consultant, researcher, legal expert and conference speaker. He has authored or co-authored more than 100 publications for scientific conferences and journals, and now devotes part of his semi-retirement to popularizing science.